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Endogenous topoisomerase II-mediated DNA
breaks drive thymic cancer predisposition
linked to ATM deficiency
Alejandro Álvarez-Quilón 1,3,4, José Terrón-Bautista 1,4, Irene Delgado-Sainz1, Almudena Serrano-Benítez1,
Rocío Romero-Granados1, Pedro Manuel Martínez-García1, Silvia Jimeno-González 1, Cristina Bernal-Lozano1,
Cristina Quintero1, Lourdes García-Quintanilla1 & Felipe Cortés-Ledesma 1,2✉
The ATM kinase is a master regulator of the DNA damage response to double-strand breaks
(DSBs) and a well-established tumour suppressor whose loss is the cause of the neurode-
generative and cancer-prone syndrome Ataxia-Telangiectasia (A-T). A-T patients and Atm−/−
mouse models are particularly predisposed to develop lymphoid cancers derived from defi-
cient repair of RAG-induced DSBs during V(D)J recombination. Here, we unexpectedly find
that specifically disturbing the repair of DSBs produced by DNA topoisomerase II (TOP2) by
genetically removing the highly specialised repair enzyme TDP2 increases the incidence of
thymic tumours in Atm−/− mice. Furthermore, we find that TOP2 strongly colocalizes with
RAG, both genome-wide and at V(D)J recombination sites, resulting in an increased endo-
genous chromosomal fragility of these regions. Thus, our findings demonstrate a strong causal
relationship between endogenous TOP2-induced DSBs and cancer development, confirming
these lesions as major drivers of ATM-deficient lymphoid malignancies, and potentially other
conditions and cancer types.
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Ataxia Telangiectasia (A-T) is the paradigm of humaninherited disease related to the DNA damage response(DDR)1,2. A-T is caused by loss-of-function mutations in
the ATM gene, and is associated with multi-systemic features,
affecting brain, gonads and the immune system; the main and
most debilitating symptom of the disease being progressive early-
onset cerebellar ataxia. Spontaneous chromosomal instability and
profound hypersensitivity to agents that induce DNA double-
strand breaks (DSBs) distinguish this syndrome from other spi-
nocerebellar ataxias3, leading to the idea of DSBs underlying A-T
symptomatology, although there is still an open debate regarding
the molecular trigger of A-T, and the specific contribution of
DSBs to the different aspects of the disease.
The connection of DSBs with immunodeficiency and cancer
predisposition in A-T is, however, well established and properly
recapitulated in the Atm−/− mouse4. During lymphocyte devel-
opment, the variable regions of T-cell receptor (TCR) and
Immunoglobulin (Ig) loci, in T and B cells respectively, are ran-
domly rearranged in a unique combination of the multiple pos-
sible V, D (in the case of TCRβ and δ and IgH) and J coding
segments present in the germline5. This shuffling occurs through
the generation of pairs of DSBs by the RAG1-RAG2 recombinase
at recombination sequence signals (RSS), and their subsequent
repair by the non-homologous end-joining (NHEJ) machinery.
ATM, although not completely required, facilitates V(D)J
recombination, providing a molecular explanation for the rela-
tively mild immunodeficiency characteristic of A-T patients and
Atm−/− mice. The main role of ATM in V(D)J recombination is
to stabilize RAG post-cleavage complexes, thus protecting DNA
ends and promoting their correct use for ligation6,7, but other
functions that are not fully understood become relevant in con-
ditions in which NHEJ is compromised8–10.
Defects in V(D)J recombination are not only responsible for
the immunological problems in A-T, but also underlie its char-
acteristic cancer predisposition. Indeed, roughly one third of
patients develop cancer, mainly lymphoma or lymphocytic leu-
kemia, which in mice manifests as very aggressive thymic neo-
plasias, with characteristics of T-cell acute lymphoblastic
leukemia (T-ALL)4. A-T and Atm−/− T-cell malignancies are
frequently linked to genome rearrangements involving the TCR
loci, strongly supporting the contribution of aberrant V(D)J
recombination. Most prevalent in A-T are translocations or
inversions (14;14) involving the TCRα/δ locus. Interestingly, this
event is also frequent in mice as a t(14;12) translocation, pro-
viding thus a molecular link between ATM-deficient T-cell
malignancies in human and mouse11–14. Furthermore, T-cell
malignancies in Atm−/− mice and human share other char-
acteristics such as chromosome 15 duplication, Notch1 amplifi-
cation and Pten deletion13,14. In the currently accepted model,
deficient V(D)J recombination and checkpoint defects caused by
ATM loss lead to persistent DSBs that engage in oncogenic
rearrangements15. Aberrant V(D)J recombination, however, is
unlikely to represent the single driver of oncogenic translocations,
as evidenced by additional V(D)J-unrelated regions of instability,
and the persistent cancer predisposition observed upon RAG
deficiency16,17. These results strongly suggest additional sources
of DSBs as relevant contributors to the ATM-deficient oncogenic
translocations responsible for T-cell cancer predisposition.
In this sense, aberrant action of DNA topoisomerase II
(TOP2) can constitute an important source of chromosomal
breakage18. The physiological function of TOP2 is to solve
topological problems arising from DNA metabolism19. To do so,
it cleaves both strands of DNA to gate the passage of another
DNA segment, via the formation of a catalytic intermediate, the
cleavage complex (TOP2cc), in which the enzyme remains
covalently linked to 5′ termini of the break. Although normally
very transient, as the DNA gate is rapidly resealed after DNA
passage, TOP2ccs can be stabilized and result in irreversible
TOP2-induced DSBs upon conflict with cellular processes and
processing of the structure by the proteasome20. Interestingly,
this does not only occur accidentally as a consequence of errors
in TOP2 catalytic cycles, but underlies the clinical efficacy of a
heterogeneous group of chemotherapeutic agents collectively
known as TOP2 “poisons”, of which etoposide is a widely
characterised paradigmatic example21. Despite substantial effi-
cacy, treatment with TOP2 poisons has been traditionally linked
to the development of secondary haematological malignancies
characterized by specific translocations22. In this regard, tran-
scription and loop extrusion, a process that organizes the gen-
ome in functional loop domains by threading chromatin through
the ring-shaped cohesin complex23–25, have been proposed as the
main source of DSBs and chromosomal translocations induced
by etoposide treatment26–29. However, the incidence and impact
of endogenous TOP2-mediated lesions in the absence of treat-
ment with TOP2 poisons and their relationship with cancer
development remain to be established. Concerning this, com-
pounds present in the diet and the environment and some forms
of pre-existing DNA damage, such as nicks or abasic sites, can
also poison TOP2 activity18.
Remarkably, TOP2-induced DSBs are characterized by har-
bouring peptide blocks derived from the enzyme that remain
covalently bound to 5′ termini through a phosphotyrosyl bond.
TDP2, with its 5′-tyrosyl-DNA-phosphodiesterese activity30,31, is
the only mammalian enzyme able to directly unblock TOP2-
induced DSBs for their repair32. Interestingly, we have previously
reported that ATM is specifically involved in facilitating repair of
TOP2-induced DSBs in a TDP2-independent fashion, probably
by promoting alternative nucleolytic pathways for the unspecific
removal of the peptide adducts33. TDP2 and ATM, therefore,
define two independent pathways for the repair of TOP2-induced
DSBs, the combined absence of which has dramatic consequences
for the cellular response to these lesions.
In the present study, we generate and characterise Atm−/−
Tdp2−/− double-deficient mice to address the occurrence and
relevance of TOP2-mediated DSBs in vivo, and, most importantly,
their possible contribution to the different aspects of A-T symp-
tomatology. We find that TDP2 loss further aggravates the pre-
disposition of Atm−/− mice to thymic malignancies, and show a
strong colocalization between RAG and TOP2 at regions that
endogenously accumulate DSBs and TOP2ccs in Atm−/− Tdp2−/−
thymocytes. These results strongly suggest the co-occurrence and
misrepair of RAG- and TOP2-mediated DSBs as a major driving
force of thymic malignancies linked to ATM deficiency.
Results
Tdp2−/− Atm−/− and Atm−/− mice are phenotypically similar.
Considering the strong sensitivity and repair defect of Tdp2−/−
Atm−/− double-deficient cells to TOP2-induced DSBs33, we
decided to address the physiological impact of these lesions in the
context of the entire organism. We reasoned that, if TOP2
damage is mediating deleterious effects in the Atm−/− mouse,
these would be further aggravated by Tdp2 loss. Mice from Tdp2
and Atm double heterozygote crosses were born at the expected
Mendelian proportions and not displaying gross abnormalities
(Supplementary Fig. 1a). Since Atm loss causes marked growth
retardation4, we measured body weight of male mice at 4 weeks of
age (Supplementary Fig.1b). As expected, Atm−/− mice showed a
more than 20% reduction in size compared to wild-type animals.
Deletion of Tdp2, however, did not have an impact on its own, as
previously reported32, neither did it aggravate the growth retar-
dation of Atm−/− mice. Furthermore, neither Tdp2−/− Atm−/−
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nor, as previously reported4, Atm−/− mice displayed clear
symptoms of neurological deficiencies or an ataxic behaviour,
which we confirmed by analysing cerebellar integrity and Pur-
kinje cellular density in 8-week old mice (Supplementary Fig. 1c).
Finally, Tdp2−/− mutation did not substantially modify the
already strong disruption of spermatogenesis found in Atm−/−
mice (Supplementary Fig. 1d).
Primary Tdp2−/−Atm−/− mouse embryonic fibroblasts
(MEFs), however, showed a marked reduction in proliferation
compared to single-mutant and wild-type cells (Supplementary
Fig. 1e), and spontaneously accumulated DSBs in unchallenged
growth conditions (Fig. 1a), with 60% of Tdp2−/−Atm−/− cells
harbouring more than one 53BP1 focus compared to 25% in wild-
type. Overall, these results suggest an accumulation of endogen-
ous DSBs in the absence of TDP2 and ATM which, at least under
certain growth conditions, can disrupt cellular fitness. The in vivo
incidence of these lesions, however, does not seem sufficiently
high to seriously compromise tissue homeostasis during devel-
opment and early stages of life.
Tdp2−/− Atm−/− mice are hypersensitive to TOP2-induced
DSBs. Given the results above, we decided to challenge Tdp2−/−
Atm−/−mice with an increased load of TOP2-induced lesions. To
do so, 8-week old adult mice of the relevant genotypes were
subjected to a single intraperitoneal injection of the TOP2-poison
etoposide (25 mg/kg). As can be seen in Fig. 1b, Tdp2−/− Atm−/−
double-knockout mice showed severe hypersensitivity to etopo-
side exposure, suffering a progressive weight loss that reached, on
average, a 15% decrease after 6 days. Histopathological analysis
revealed marked villous atrophy in the small intestine mucosa,
which is a known etoposide target, as the likely cause of the
drastic weight loss in Tdp2−/− Atm−/− (Fig. 1b). In contrast, at
this low etoposide concentration, wild-type and Atm−/− animals
did not respond negatively to the treatment, while Tdp2−/− did so
only mildly. This synergistic hypersensitivity of Tdp2−/− Atm−/−
mice to etoposide suggests a protective role of ATM against the
adverse effects of TOP2 lesions in vivo, but only when TDP2 is
absent, which recapitulates cellular observations in the context of
the entire organism33.
TDP2 loss increases thymic cancer predisposition of Atm−/−.
We decided to analyse Tdp2−/− Atm−/−mice over a longer period,
to allow an accumulation of a higher load of TOP2-mediated
damage and/or the development of potential pathologies. For this,
weight and general health status were monitored weekly in a
minimum of 20 mice for each of the relevant genotypes, until
reaching the experimental endpoint of 2 years (730 days) (Fig. 2a).
As previously reported, we observed that Atm−/− mice showed a
reduced life-span with an important number of animals suc-
cumbing to thymic neoplasia after the first few months of life
(Fig. 2b, Supplementary Fig. 2a). Furthermore, a molecular char-
acterization of the cellular content in these tumours showed a
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Fig. 1 Tdp2−/− Atm−/− causes the spontaneous accumulation of DSBs and etoposide hypersensitivity in mice. a Endogenous DSB occurrence in
Tdp2+/+ Atm+/+, Tdp2−/− Atm+/+, Tdp2+/+ Atm−/− and Tdp2−/− Atm−/− primary MEFs measured by 53BP1 foci formation. The percentage of cells with
more than one focus (left) and representative images (right) of 53BP1 foci (green) and DAPI staining (blue) are shown for each genotype. MEFs isolated
from three different embryos were analysed per condition. Mean ± SEM and statistical significance by one-way ANOVA with Bonferroni post-test is shown
(F= 5,402). b Body weight of 8-week old mice cohorts intraperitoneally injected with a single dose of etoposide (25mg/kg). Average ± SEM of the
percentage of initial body weight from five mice and statistical significance by Two-way ANOVA with Bonferroni post-test is shown (F= 29,11). Tdp2+
indicates both Tdp2+/+ and Tdp2+/− genotypes. Representative images of Haematoxylin-Eosin stained jejunum slices obtained 6 days after etoposide
exposure are shown.
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majority (70%) of double positive CD4+ CD8+ T-cell tumours
(Fig. 2c, Supplementary Fig. 2b), consistent with the reported
T-ALL predisposition.
Single Tdp2−/− mice had a lifespan comparable to wild-type
(Fig. 2a), and none of the animals developed thymic lymphoma
within the course of the experiment (2 years). Strikingly however, in
Atm−/− background, both the reduced overall life-span and the
incidence of thymic tumours were largely aggravated by Tdp2
inactivation (Fig. 2a, b). Thus, Tdp2−/−Atm−/− mice showed a
median survival of 140 days, contrasting with 307 days for the
Atm−/− single mutant (Fig. 2a), and the probability of developing a
thymic tumour during the 1st year of life increased from a 43% in
Atm−/− to a 72% in the Tdp2−/−Atm−/− double mutant (Fig. 2b).
Importantly, lifespan of Tdp2−/−Atm−/− and Atm−/− mice that did
develop a thymic tumour was not significantly different (Fig. 2d),
suggesting a direct effect on the incidence and not on the latency or
aggressiveness of T-cell malignancies. In this sense, tumours observed
in Tdp2−/−Atm−/−mice were also predominantly formed by double
positive CD4+ CD8+ T-cell precursors (80%) (Fig. 2c). Double-
knockout mice, however, did not show differential distribution in
the populations of double negative (CD4−CD8−), double positive
(CD4+CD8+) or single positives (CD4+ or CD8+) thymocytes
compared to Atm−/− mice (Supplementary Fig. 2c), suggesting that
the increased incidence of T-cell malignancy caused by TDP2 loss
is unlikely to reflect further disruption of V(D)J recombination.
In the same way, pre-B-cell, pro-B-cell and immature B-cell
populations did not differ between single Atm−/− and double
Tdp2−/−Atm−/− knock-out mice (Supplementary Fig. 2d), further
supporting the idea that V(D)J recombination is not substantially
altered by TDP2 loss.
The checkpoint and proapoptotic functions of ATM, which are
strongly signalled through the p53-dependent pathway, are
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Fig. 2 TDP2 deficiency increases thymic cancer predisposition of Atm−/− but not of Tpr53−/− mice. a, b Kaplan–Meier survival curve (a) and
cumulative occurrence (b) of thymic tumours during the 1st year of life of at least 20 mice with the indicated Tdp2 and Atm genotypes. n= 21 (Tdp2+/+
Atm+/+), n= 23 (Tdp2−/− Atm+/+), n= 23 (Tdp2+/+ Atm−/−), n= 21 (Tdp2−/− Atm−/−). Tdp2+ indicates both Tdp2+/+ and Tdp2+/− genotypes.
Statistical significance by two-sided Wilcoxon test is indicated. c Percentage of tumours composed by immature CD4+ CD8+ double positive, or
CD4+/CD8+ single positive lymphocytes in the indicated genotypes. Thymocytes were selected by size and complexity prior classification by high or low
CD4 and CD8 markers (see Supplementary Fig. 1a for gating strategy). d Median life-span of Tdp2+/+ Atm−/− and Tdp2−/− Atm−/− mice affected by a
thymic tumour (n= 11 and n= 16 for Tdp2+/+ Atm−/− and Tdp2−/− Atm−/− mice respectively). e Kaplan–Meier survival curve and f cumulative incidence
of thymic tumours of the indicated Tdp2 and Trp53 genotypes (n= 16 for Tdp2+/+ and n= 22 for Tdp2−/−).
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known to be determinant for Atm−/− cancer predisposition15.
Consistent with this, p53-deficient Trp53−/− mice are also highly
susceptible to the development of double positive CD4+CD8+
thymic tumours34. In order to discern between the contribution
of repair and checkpoint/apoptotic functions of ATM in the
increased incidence of thymic tumours in Tdp2−/−Atm−/−, we
analysed life span and tumour incidence in Tdp2−/−Trp53−/−
animals, in which the repair component is not substantially
affected. In contrast to what was observed in Atm−/− background
(Fig. 2a, b), loss of functional TDP2 did not significantly decrease
lifespan (Fig. 2e), nor increase the high incidence of cancer
(Supplementary Fig. 2e), and thymic lymphoma in particular
(Fig. 2f), observed in Trp53−/− animals. This suggests that
Tdp2−/−Atm−/− tumours likely reflect direct functions of ATM
in the repair of TOP2-induced DSBs, and not only in their
signalling for checkpoint and apoptosis. Overall, the results are
consistent with a model in which misrepair of TOP2-induced
DSBs can strongly contribute to the development of thymic
tumours characteristic of ATM deficiency.
Tdp2−/−Atm−/− and Atm−/− malignancies are molecularly
similar. In order to gain insights into the molecular events
responsible for thymic tumour development in Tdp2−/−Atm−/−
mice, we analysed and compared copy-number variation by com-
parative genomic hybridization (CGH) in six Tdp2−/−Atm−/− and
three Atm−/− thymic tumours (Fig. 3a, Supplementary Fig. 3
and Supplementary Table 1). In Atm−/− animals (Fig. 3a, b), we
observed the previously reported features of genomic instabil-
ity13, with amplification upstream of the Tcra/d locus in chro-
mosome 14 (2 out of 3 mice) and variable hemizygous loss of a
Bcl11b-containing telomeric region of chromosome 12 (all 3
mice), which are indicative of the frequent t(14;12) translocation
and subsequent breakage-fusion-bridge cycles. In addition, one
mouse displayed instability at the Tcrb locus, with both gain and
loss of DNA sequence. Two of the three animals also presented
the characteristic duplication of chromosome 15. Also, two
animals presented deletions in chromosome 19 covering the
Pten tumour suppressor, although only in one of the cases this
corresponded to the previously reported homozygous loss13.
Finally, we did not observe amplification of Notch1 in chro-
mosome 2, which is another common, although less frequent,
feature in Atm−/− T-cell malignancies.
Surprisingly, we observed very similar features in Tdp2−/−Atm−/−
mice (Fig. 3a, b). Four out of six tumours presented Tcra/d linked
amplification, and all six showed chromosome 12 deletion with
Bcl11b loss. Instability at the Tcrb locus was also observed in two
of the six cases. Trisomy of chromosome 15 was also observed in
four of the six animals, while only one of the six cases carried
Notch1 amplification. All these events were coincident with the
results obtained in Atm−/− animals (see above) and previous
reports13. Finally, as observed for Atm−/−, one Tdp2−/−Atm−/−
animal displayed hemizygous Pten loss as part of a larger
deletion. The variable length of the copy-number variation
events at common regions, together with additional sites of
instability that are unique to individual tumours (Supplementary
Fig. 3), are indicative of the stochastic nature of the oncogenic
events. In summary, we can conclude that loss of TDP2 increases
the incidence of the same oncogenic rearrangements that drive
thymic tumour in Atm−/− animals, suggesting a strong
contribution of TOP2-mediated lesions to ATM-deficient T-cell
cancer predisposition.
TOP2B is enriched at sites of DSB accumulation. In order to
further establish aberrant TOP2 activity as a direct contributor to
Atm−/− oncogenic T-cell genome rearrangements, we decided to
map binding of topoisomerase IIß (TOP2B), which is the main
source of TOP2 activity in G1 and non-cycling cells. ChIPseq
analysis in freshly isolated thymocytes from wild-type mice
revealed a pattern of TOP2B distribution consistent with that
previously found in other cell types and tissues35–37 (Fig. 4a),
with a clear enrichment at promoter, enhancer and insulator
regions (34%, 19% and 13% of TOP2B peaks, respectively). In
fact, regardless of the type of functional element analysed, and as
previously reported36, we observed a strong correlation between
TOP2B and the core cohesin subunit RAD21, with 81% of
TOP2B peaks overlapping with those of cohesin (Fig. 4b), and
detectable cohesin signal in virtually all TOP2B peaks, regardless
of the presence of RNA polymerase II (POLR2A) or the insu-
lating architectural protein CTCF (Fig. 4c). Fig. 4d shows the
Cxcr4 locus merely as an illustrative example of TOP2B and
cohesin co-localization within promoter (left) and insulator
(right) regions. These results are consistent with the proposed
connection between TOP2B function and 3D-genome
organisation36,37.
We decided to specifically study TOP2B occupancy at
particular sites related to Atm−/− oncogenic translocations,
integrating published maps of endogenous DSB accumulation
determined by ENDseq in Atm−/− thymocytes 38. When
concentrated on the Bcl11b, Notch1, and Pten loci (Fig. 5a–c),
we observed clear TOP2B binding at all of these regions with
strong accumulation at the promoters and towards the 3’ end of
the genes, with a pattern following that of cohesin and RNA-
polymerase II (POLR2A). This TOP2B accumulation was not
thymocyte-specific, as a similar pattern was observed in MEFs
(shown for Bcl11b, Supplementary Fig. 4a). In order to directly
identify regions of DSB accumulation in Atm−/− thymocytes, we
selected ENDseq peaks specific for Atm−/− thymocytes (high-
lighted in yellow; Fig. 5a–c). Interestingly, when these sites were
compared with the distribution of TOP2B, overlap was highly
variable with examples of both unique and common regions;
compare region 1 and region 2 in Pten (Fig. 5c). TOP2B is
therefore present at Atm−/− unstable regions, but it is difficult to
establish a direct association with DSB accumulation, and may be
a mere consequence of its widespread distribution at regulatory
regions. Furthermore, the difficulty to assign original transloca-
tion breakpoints with sufficient precision strongly limits our
capacity to directly link TOP2B binding to oncogenic DSB
occurrence at these specific locations.
Based on this, we decided to compare the distribution of
TOP2B and ENDseq signal at a genome-wide level. We
observed a clear accumulation of DSBs at TOP2B peaks
(Fig. 5d), supportive of a link between TOP2B function and
spontaneous chromosome fragility, in the same line as what has
been previously reported for etoposide treatments37. Conver-
sely, and further supportive of this TOP2B-DSB association,
ENDseq peaks displayed an accumulation of TOP2B signal
(Fig. 5e). Most prominent peaks of ENDseq signal in
thymocytes are known to be associated with RSS sites,
disappearing in Rag2−/− and strongly accumulating in Atm−/−
cells38, consistent with the high incidence and precision of RAG
cleavage and the reported roles of ATM in facilitating V(D)J
recombination. At TOP2B sites, however, DSBs were noticeably
increased in both Rag2−/− and Atm−/− thymocytes (Fig. 5d),
demonstrating that they are unrelated to RAG cleavage, and
suggesting that these lesions can accumulate upon ATM
deficiency. In summary, there is a significant genome-wide
correlation between sites of TOP2B function and occurrence of
RAG-independent endogenous DSBs in thymocytes, suggesting
aberrant TOP2B activity as an additional relevant source of
chromosome breakage that could contribute to characteristic
Atm−/− oncogenic translocations.
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TOP2B and cohesin colocalize with the RAG endonuclease.
Based on the results above, we decided to check how RAG and
TOP2B contribute to DSB accumulation in more detail. In order
to do so, we analysed TOP2B, RAD21 and ENDseq signal in
previously reported peaks of RAG1 and RAG212 (Fig. 6a–c).
RAG2 has a wide distribution with a strong presence at active
promoters displaying the H3K4me3 histone mark, while the
presence of RAG1 is more restricted, only co-localizing with a
fraction of RAG2 peaks39,40. We observed a striking genome-wide
co-localization of TOP2B and RAD21 with RAG2, which was
irrespective of the strong presence of RAG1 or not (Fig. 6a). Thus,
clear TOP2B accumulation was observed in peaks containing
both RAG1 and RAG2 but also in those containing mostly RAG2
(Fig. 6a, b). In addition, 42% of TOP2B peaks colocalized with
RAG (merge of RAG1 and RAG2 peaks) (Fig. 6b), consistent with
their mutual enrichment at H3K4me3-positive promoter regions.
In any case, although some ENDseq signal was observed at these
regions, the accumulation of DSBs was not clear or sufficiently
localized (Fig. 6a). Interestingly, when directly compared, spon-
taneous DSB accumulation was more robust at TOP2B and
cohesin than at RAG1 or RAG2 peaks, both in wild-type and
Atm−/− thymocytes (Fig. 6d). Altogether, these results uncover a
surprising genome-wide connection between RAG and TOP2B-
cohesin, and suggest that, when analysed globally, TOP2B activity
can constitute an important source of DNA breakage in Atm−/−
thymocytes, quantitatively more relevant than DSBs directly
induced by RAG.
Based on this genome-wide colocalization between TOP2B and
RAG, we decided to check the distribution of TOP2B specifically
at sites actively undergoing V(D)J recombination in thymocytes
(Fig. 7a–c; Supplementary Fig. 5a, b); this includes the Tcra/d,
Tcrb, Tcrg and IgH15 loci. Strikingly, sites of strong and localized
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TOP2B accumulation were observed at all of these sites, and were
particularly enriched at the V(D)J-initiating J segments. As
expected, TOP2B coincided with the position of the cohesin
subunit RAD21, and, in line with the genome-wide observations,
also with the strongest peaks of RAG1 and RAG2. Furthermore,
the TOP2B-cohesin sites concurred with a very strong ENDseq
signal that was further enhanced in Atm−/− thymocytes.
Interestingly however, DSB accumulation in these regions was
completely dependent on RAG, and did not fully coincide with
TOP2B-cohesin peaks, but was displaced a few kbs from TOP2B
sites (Supplementary Fig. 6). This demonstrates that direct RAG
cleavage, rather than aberrant TOP2B activity, is the main source
of DSBs at Tcr and Igh loci in thymocytes, but suggests a strong
association between TOP2B-cohesin function and sites under-
going active V(D)J recombination. In support of this, TOP2B
accumulation in these regions was specific to thymocytes when
compared to peaks called in MEFs (Supplementary Fig. 4b, c).
ChIPseq of TOP2A also evidenced that TOP2 enrichment was
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preferential for the TOP2B isoform, both at V(D)J recombination
sites and other genes related with the observed oncogenic
translocations (Supplementary Fig. 4). Furthermore, when END-
seq signal at Tcrb was analysed in detail, there were two peaks
that became apparent when the predominant signal derived from
RAG cleavage was lost in Rag2−/− thymocytes (Fig. 7c; ENDseq
Rag2−/− autoscaled). This relocation of ENDseq signal from
major sites of RAG cleavage to additional less prominent sites
may be responsible for the apparent increase in DSBs observed at
TOP2B peaks in Rag2−/− background (Figs. 5a and 6d). In any
case, similarly to what occurred on a genome-wide scale and at
other particular locations (Fig. 5), these regions of DSB
accumulation were perfectly coincident with the two major sites
of TOP2B and RAD21 binding, further supporting an association
between TOP2B function and RAG-independent DNA breakage.
Nevertheless, despite a similar localized accumulation of TOP2B-
cohesin, RAG-independent ENDseq signal was below detection
levels at other Tcr and Igh loci (Fig. 7a, b; Supplementary Fig. 5),
indicating some degree of variability in the incidence and/or
detection of TOP2B-mediated DSBs at these regions.
Tdp2−/− Atm−/− thymocytes accumulate endogenous TOP2
DSBs. To directly confirm aberrant TOP2B activity as a relevant
source of DSB accumulation in Tdp2−/− Atm−/− thymocytes, we
used a technique recently developed in the laboratory, ICE-IP, in
which TOP2 covalently attached to DNA is immunoprecipitated,
and the abundance of the genomic region of interest is measured
by qPCR (see the “Methods” section and Supplementary Fig. 7 for
a detailed description). This allows locus-specific detection of
TOP2ccs and TOP2-induced DSBs in which TOP2 has not been
fully degraded or removed. In order to be able to detect endo-
genous lesions, we included a step of nested amplification. We
first concentrated on two regions of Tcrb in which RAG-
independent ENDseq peaks were detected (region 1 and region
2 in Fig. 7c). Interestingly, TOP2B ICE-IP in freshly isolated
thymocytes showed a very clear enrichment of covalently
attached TOP2B, exclusively, or at least only significantly, in
Tdp2−/−Atm−/− thymocytes, with a >10-fold increase compared
to wild-type animals (Fig. 7d). We then tested two regions of Pten
with Atm−/−-specific ENDseq signal, one that coincided with a
strong TOP2B signal and one that did not (region 1 and region 2
in Fig. 5c, respectively). As expected, covalently attached TOP2B
accumulated to significant levels only in region 1 of Pten in
Tdp2−/−Atm−/− thymocytes, and neither in region 2, nor in
wild-type or single-mutant cells. These results strongly support
the idea that TDP2 and ATM independently operate to prevent
the endogenous accumulation of TOP2B-blocked DSBs, both
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globally at particular regions throughout the genome, and spe-
cifically at sites undergoing V(D)J recombination.
Finally, in order to reinforce the idea that the rearrangements
found in thymic lymphomas could be related to 3D-genome
folding and the functions of TOP2B in this process, available
Hi–C maps on wild-type thymocytes 41 were integrated with
hotspots of Atm−/−-linked genomic instability. As a matter of
fact, V(D)J recombination sites and other unstable sites were
clearly associated with regions of strong long-range interactions
(in the order of megabases), apparent as borders of squares in the
contact density map (Supplementary Fig. 8), and that could be
associated to topologically associating domains (TADs) borders.
Interestingly, these regions have been shown to be particularly
prone to breakage and instability in general 42,43, and to the
accumulation of etoposide-induced DSBs in particular37, which
has led to the idea of TOP2 activity at these functional elements
of genome organization as a potential major driver of oncogenic
translocations28,29.
Discussion
In this study, we show that the absence of TDP2 function sig-
nificantly aggravates the predisposition of Atm−/− mice to
develop thymic malignancies (Fig. 2). Furthermore, TOP2B
genome-wide binding correlates with sites of endogenous DSB
accumulation (Fig. 5), and endogenous TOP2B-blocked lesions
indeed accumulate in Tdp2−/−Atm−/− thymocytes (Fig. 7). These
observations strongly support TOP2B-mediated DSBs as
potential drivers of tumour development, at least in the particular
setting of A-T-linked cancer predisposition, establishing a causal
connection between misrepair of endogenous TOP2 lesions and
tumorigenesis. In this sense, the implications of these results
reach beyond our understanding of A-T cancer predisposition,
since ATM is a well-established tumour suppressor, very fre-
quently mutated in in many tumour types, and lymphoid
malignancies in particular44.
Interestingly, thymic tumours in Tdp2−/− Atm−/− mice dis-
play identical characteristics to those of Atm−/− animals, with a
very aggressive form of T-ALL associated to recurrent clonal
genome rearrangements enriched at loci undergoing V(D)J
recombination (Figs. 2–3; Supplementary Fig. 2–3 and Supple-
mentary Table 1). This is, in principle, difficult to reconcile with
the incidence of thymic malignancies being increased by loss of
TDP2, an enzyme that is highly specialized in TOP2-mediated
DSBs, and therefore completely unnecessary for the repair of
hairpin DNA ends produced by RAG. Nevertheless, one must
bear in mind that translocations require two DSBs, so that TOP2-
mediated lesions can contribute to the oncogenic events by pro-
viding partners for rearrangements that also engage Tcr or Ig loci,
being the co-occurrence of TOP2- and RAG-mediated DNA
breaks, and their stabilization and misrepair upon ATM loss, and
not RAG-induced breaks per se, what drives ATM-deficient
thymic lymphoma predisposition. This would occur in two dif-
ferent scenarios (Fig. 8).
First, we consider TOP2-induced DSBs appearing indepen-
dently of V(D)J recombination (Fig. 8, top). In this situation,
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aberrant TOP2 activity, which accidentally occurs throughout the
genome as a consequence of genome organization or the removal
of transcription-associated supercoiling27,37, results in the for-
mation of DSBs that are normally repaired very efficiently by the
action of either TDP2- or ATM-dependent repair pathways33.
Furthermore, the checkpoint functions of ATM trigger cell cycle
arrest and/or apoptosis if these breaks remain unresolved. A
combined failure to properly repair and signal TOP2-mediated
DSBs, which can occur accidentally, but is greatly enhanced in the
Tdp2−/− Atm−/− mutant, leads to the persistence and propaga-
tion of these lesions, as has been shown to occur with RAG-
induced DSBs upon single ATM deficiency15. This substantially
increases the probability of at least two DSBs concurring in time
during thymocyte development, providing ideal conditions for
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the generation of chromosomal translocations that can drive
oncogenesis. As a matter of fact, irradiation of Atm−/− B-cells has
been shown to increase translocations involving the Igh locus15,
strongly supporting the idea that additional sources of DSBs can
enhance translocation frequency by providing partners for rear-
rangements with loci undergoing V(D)J recombination. Never-
theless, it is clear that, as previously suggested, off-target RAG
cleavage can also constitute a source of additional DSBs during
thymocyte development40. In this context, the striking genome-
wide correlation between TOP2B and RAG binding (Fig. 6)
complicates to unambiguously establish their individual con-
tribution to endogenous DNA breakage. The fact of ENDseq
signal being quantitatively more relevant at TOP2B than at RAG2
peaks, however, strongly vouches for aberrant TOP2 activity as a
major source of endogenous DSB occurrence genome wide.
Second, we consider a scenario in which TOP2-induced DSBs
appear associated to V(D)J recombination (Fig. 8, bottom). The
chromatin movements and changes in the three-dimensional
conformation that necessarily accompany the process of V(D)J
recombination result in topological problems that lead to parti-
cularly elevated levels of TOP2 activity at these regions, and
therefore an increased probability of DSBs to occur. These TOP2-
mediated DSBs concur both in time and space with RAG cleavage,
constituting a particularly challenging and genome-threatening
situation. This possibility is particularly appealing in the context of
the recent RAG-scanning models, which invoke cohesin-mediated
loop extrusion to explain how RAG finds and pairs RSSs23. Once
RAG is loaded to form a V(D)J recombination centre, chromatin
threading through the cohesin ring would allow RAG to linearly
scan the extruded region and find a second RSS for pairing and
cleavage. As has been proposed for general loop extrusion, TOP2
would facilitate RAG scanning by removing topological problems
that are encountered by the extruding complex, but, as mentioned
above, could result in the formation of DSBs that compromise the
integrity of these regions37. Thus, the strong thymocyte-specific
co-localization of TOP2B-cohesin with RAG at sites actively
undergoing V(D)J recombination does not only provide us with a
potential additional source of instability at these sites, but can
actually be taken as an important support for a loop-extrusion
model of RAG scanning.
In summary, we provide a causal link between endogenously
occurring TOP2-induced DSBs and cancer development, putting
forward these lesions as important contributors to T-cell malig-
nancies related to ATM loss, and opening the door for their
potential involvement in other conditions and cancer types.
Furthermore, we present evidence for the involvement of TOP2B
in resolving topological problems derived from the chromatin
movements and changes in genome conformation required for V
(D)J recombination, providing an additional source of chromo-
some fragility at these regions beyond direct RAG cleavage, and
supporting a model of loop extrusion-mediated RAG scanning
for target RSS pairing.
Methods
Animal maintenance. All animal procedures were performed in accordance with
European Union legislation and with the approval of the Ethical Committee for
Animal Experimentation of CABIMER and validation by the Regional Government of
Andalusia (Consejería de Agricultura, Ganadería, Pesca y Desarrollo Sostenible de la
Junta de Andalucía). Double heterozygotes Tdp2+/−Atm+/− and Tdp2+/−Trp53+/−
were obtained by the crossing Tdp2+/−32 with Atm+/−4 or Trp53+/−45. The colonies
were maintained by crossing double-heterozygotes and littermates were used for
experiments. Animals were housed in isolated cages with controlled ventilation trough
HEPA-filters, kept under standard housing conditions (21 ± 1 °C with a photoperiod
of 12:12 h), and manipulated in flow cabins. Sterile food pellets and water were
available ad libitum. Mice were genotyped using Phire Animal Tissue Direct PCR Kit
(Thermo) following manufacturer instructions.
In vivo etoposide sensitivity. At 8 weeks of age, mice underwent intraperitoneal
injection with 3 µl/g of body weight of either DMSO (vehicle control) or etoposide
at 25 mg/ml in DMSO for a final dose of 25 mg/kg. Weight and general health
status were monitored daily from the day of injection (inclusive). Six days post-
treatment mice were sacrificed by cervical dislocation and dissected for histo-
pathological analysis. For this, organs were fixed in 4% paraformaldehyde for
2 days, embedded in paraffin, cut in 6 µm slices by microtome, stained with
Haematoxylin-Eosin and visualized under the microscope.
Lifespan analysis. Minimum 20 mice per experimental condition were included in
the analysis. Weight and general health status were monitored weekly. Animals
were sacrificed by cervical dislocation and dissected for histopathological analysis
in the case of showing a 20% loss of the maximum weight, the presence of a
detectable tumour or signs of evident pain. Thymic lymphoma was macro-
scopically identified and confirmed by histopathological analysis. Overall survival
and cumulative occurrence of thymic tumours were determined by Kaplan–Meier
curves and statistically analysed with Wilcoxon tests.
Histological analysis. Cerebella were fixed in 4% paraformaldehyde, embedded in
paraffin, and sagittal 50 µm slices were obtained by vibratome. Immunohis-
tochemistry was performed using anti-calbindin primary antibody (CB-38a, Swant)
and Biotin-SP AffiniPure Goat Anti-Rabbit secondary antibody (111-065-003,
Jackson). Signal was developed using VECTASTAIN Elite ABC HRP Kit (Pk-6100,
Vector Laboratories) and DAB (D4418-50SET, Sigma).
For histological analysis of testicles, organs were fixed in 4% paraformaldehyde,
embedded in paraffin, cut in 6 µm slices by microtome and stained with
Haematoxylin-Eosin.
Cellular index assay. Primary MEFs were isolated from littermate embryos at day
13 p.c. and cultured at 37 °C, 5% CO2 and 3% O2 in Dubelcco's Modified Eagle's
Medium (DMEM) supplemented with penicillin, streptomycin, 15% FCS and non-
essential aminoacids. MEFs were plated in E-plates 16 in duplicates in a con-
centration of 4000 cells per well and analysed by xCELLigence® RTCA DP (ACEA
Bioscences). The instrument measures cellular proliferation by changes in
impedance-based signals in real time. Three independent sets of primary MEFs
cells were analysed.
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Fig. 8 Model to explain aberrant TOP2 activity as a driver of ATM-
deficient thymic malignancies. TOP2 activity associated with genome
organization and transcription throughout the genome can accidentally
result in DSBs (top). Additionally, DSBs can arise as a consequence of
TOP2 activity derived from genomic reorganization associated to V(D)J
recombination, and in particular, the mechanism of RAG scanning to find its
RSS targets (bottom). These DSBs concur with RAG-mediated DSBs,
increasing the probability of oncogenic translocations to occur. Efficient
repair of TOP2-induced DSBs mediated by either TDP2 or ATM-dependent
pathways, together with the checkpoint and apoptotic functions of ATM,
strongly limit the oncogenic potential of these lesions.
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Lymphocyte analysis. Healthy thymus (4-weeks old) or thymic lymphomas were
extracted from mice, disaggregated to single cells in EDTA-buffer (100 mM NaCl,
1 mM KH2PO4, 3 mM KCl, 10 mM Na2HPO4, 1 mM EDTA) and immunostained
with anti-CD4-FITC and anti-CD8-APC. Samples were fixed 10 min in 4% par-
aformaldehyde for storage at 4 °C, and subsequently analysed using a BD FACS-
Calibur Flow Cytometer (BD Biosciences). Data was processed and analysed using
FlowJo (v9, FlowJo, LLC).
FACS analysis. B-cell populations were isolated from 5-week old mice femur
passing 2 ml of ice-cold EDTA buffer (100 mM NaCl, 1 mM KH2PO4, 3 mM KCl,
10 mM Na2HPO4, 1 mM EDTA) through the femur bone marrow using a 25-G
needle syringe. Cells were centrifuged 10 seg at 10,000 rpm in a bench centrifuge
and resuspended in 500 µl of PBS-5% FBS (blocking, 30 min). After blocking, 1:100
dilution of conjugated antibodies was added to the samples and incubated on ice
for another 30 min. Cells were then washed twice with PBS-5%FBS (centrifuge
10 seg, 10000 rpm) and fixed adding 200 µl of 4%PFA-PBS drop by drop to cells
resuspended in 20 µl of PBS. After 10 min of incubation, cells were washed with
PBS and analysed by FACScalibur flow cytometer (Becton Dickinson). Antibodies:
B220-APC (17–0452) and CD43-FITC (11–0431). CD43+ B220+ cells were con-
sidered Pro-B-cells, CD43- B220low Pre-B-cells and CD43- and B220high immature
B-cells. Data was processed and analysed using FlowJo (v9, FlowJo, LLC).
CGH analysis. Genomic DNA was purified from thymic tumours and kidney from
Tdp2+/+Atm−/− or Tdp2−/−Atm−/− mice using DNeasy Blood and Tissue Kit
(Qiagen) following manufacturer recommendations. One microgram of genomic
DNA from thymic lymphoma was profiled against 1 µg of matched normal kidney
DNA from the same mouse. Processing, labelling and hybridization to Mouse
Genome CGH Microarray 2 × 105 K (G4425B-014699, Agilent) was performed at
the CBIMER Genomics Facility. Data was processed using the package snapCGH
within R (version 3.3.1). Background correction was applied to fluorescence ratios of
scanned images using the method ‘minimum’. To compare hybridizations, nor-
malization between arrays by the method ‘scale’ was performed. Finally, data was
processed and ordered by the function ‘processCGH’, and fluorescence ratios were
plotted using the R function ‘plot’ and the package Gviz46. Thresholds for copy
number alterations were set at log2= ±0.6 for trisomy or hemizygous deletion.
Immunofluorescence. DSBs in primary MEFs were measured by 53BP1 foci.
MEFs were grown on coverslips for 1 day in DMEM supplemented with penicillin,
streptomycin, 15% FCS and non-essential aminoacids (37 °C, 5% CO2 and 3% O2)
and then fixed for 10 min in ice-cold methanol at −20 °C. Cells were permeabilized
for 2 min in PBS−0,2% Triton X-100 and blocked for 30 min in PBS−5% BSA.
Coverslips were then incubated with the primary antibody (SantaCruz – sc22760)
diluted 1:1000 in PBS−1% BSA for 1 h. After three washes of PBS−0,1% Tween 20,
cells were incubated 30 min with the AlexaFluor-conjugated secondary antibody
diluted 1:1000 in PBS−1% BSA (Jackson ImmunoResearch − 111-545-144) and
washed three times with PBS−0,1% Tween 20. Finally, cells were counterstained
with DAPI (Sigma) and mounted in Vectashield (Vector Labs). 53bp1 foci were
counted manually (double-blind) in 40 cells per condition using ZEISS ApoTome
microscope.
ICE-IP (in vivo complex of enzymes immunoprecipitation). Cells from thymus
medulla were isolated from 5-week old mice and placed into RPMI 20% FBS media
for 3 h in order to collect only thymocytes in suspension. Cells were then collected
by centrifugation at 300 × g 5 min and resuspended into 1% (w/v) N-
Lauroylsarcosine sodium salt (Sigma-Aldrich, L7414) in TE buffer with complete
protease inhibitor cocktail (Roche) for a denaturizing lysis of cells. Lysates were
then homogenized using 25G syringe and subjected to DNA precipitation using a
CsCl (Applichem-Panreac, A1098) density gradient. DNA was precipitated only
with covalently bound proteins adding CsCl to a final concentration of 0,67 g/ml
and centrifuging at 57,000 rpm for 20 h at 25 °C using 3.3 ml 13 × 33 polyallomer
Optiseal tubes (Beckman Coulter) in a TLN100 rotor (Beckman Coulter).
Forty micrograms of non-crosslinked DNA were digested for 6 h with HindIII-
HF (NEB, R3104) and NdeI (NEB, R0111) restriction enzymes at 1 U/μl each one.
Samples were then diluted five times in IP buffer (0,1% SDS, 1% TX-100, 2 mM
EDTA, 20 mM TrisHCl pH8, 150 mM NaCl) and incubated o/n at 4 °C with 2 μg of
TOP2B antibody (NOVUS, NB100-40842) and then with 25 μL of pre-blocked (1
mg/ml BSA) Dynabeads protein A and Dynabeads protein G (ThermoFisher).
Beads were then sequentially washed with IP buffer, IP buffer containing 500 mM
NaCl and LiCl buffer (0.25 M LiCl, 1% NP40, 1% NaDoc, 20 mM TrisHCl pH8 and
1mM EDTA). DNA was eluted by 30 min incubation at 30 °C in 100 μL elution
buffer (1% SDS, 100 mM NaHCO3) and then treated with 10 μg of Proteinase K
(ThermoFisher) for 2 h at 37 °C prior to purification using Sera-Mag Select beads
(GE Healthcare). Sites of interest were amplified using GO-TAQ polymerase and
purified again using Sera-Mag Select beads before qPCR with nested primers. In
order to avoid PCR saturation, the number of cycles (between 10 and 20) in the
first PCR reaction were determined for each pair of primers to results in a range of
25–30 Cqs in the subsequent qPCR. Results for each region of interest were
normalized against input and an intergenic control region which does not show
significant TOP2B binding.
Primers for PCR: Tcrb-Region1 (FW: GGAGACCCAGAACAGAGCAG, RV:
ATAAATAGGGCTGGGGATGG), Tcrb-Region2 (FW: CACCTGCCATAGCTC
CATCT, RV: CGGTGATAGCTAGAGGCTGAG), Pten-Region 1(FW: ACTGGCA
AGCCAAGCTTAAA, RV: GTGGTTGGTTTCCTGCAGTT), Pten-Region 2 (FW:
AACTCCGCTGTGAATTTTGG, RV: CTTTGGGAGGACATGCTAGG) and
Control Region (FW: AGGAGAGAATGGAGACAAGAGC, RV: GGTCTCTATC
ACTGTTCTCATTGG).
Nested primers for qPCR: Tcrb-Region1 (FW: GGAGACCCAGAACAGAGC
AG, RV: ATAAATAGGGCTGGGGATGG), Tcrb-Region2 (FW: AGCTCCATC
TCCAGGAGTCA, RV: TGAGGTAGAAAGGGCTGCAT), Pten-Region1 (FW:
CCCCTCCCCACTTCTATTGT, RV: GTGGTTGGTTTCCTGCAGTT), Pten-
Region2 (FW: CCGCTGTGAATTTTGGCTAT, RV: GCCTGTGAAACAGTGC
TCAA) and Control Region (FW: TCACTGTTCTCATTGGTTGC, RV: CTCAGG
AGTGTCAGGGAAGG).
ChIPseq. To prepare chromatin, mouse thymus was extracted from 4–6-week old
mice, washed twice with cold PBS and mechanically disaggregated into single cells
in 1ml EDTA buffer (100 mM NaCl, 1 mM KH2PO4, 3 mM KCl, 10 mM Na2HPO4,
1 mM EDTA). Thymocytes were then washed twice and resuspended again in
EDTA buffer. Cells were fixed in a final concentration of 1% formaldehyde and
incubated at 37 °C for 10 min. Fixation was quenched by adding glycine to a final
concentration of 125 mM. Cells were washed twice with cold PBS in the presence of
complete protease inhibitor cocktail (Roche) and PMSF. Cell pellet was lysed in
two steps using 0.5% NP-40 buffer for nucleus isolation and SDS 1% lysis buffer for
nuclear lysis. Sonication was performed using Bioruptor (Diagenode, UCD-200) at
high intensity and two cycles of 10 min (30” sonication, 30” pause) and chromatin
was clarified by centrifugation (17,000 × g, 10 min, 4 °C).
For IP, 50 μg chromatin and 4 μg antibody (anti-TOP2B NOVUS-NB100–40842,
anti-TOP2B SantaCruz-sc13059, anti-TOP2A Abcam-EP1102Y and rabbit IgG
SIGMA-I8140 as control) were incubated o/n in IP buffer at 4 °C, and then with
25 μL of pre-blocked (1mg/ml BSA) Dynabeads protein A and Dynabeads protein G
(ThermoFisher). Beads were then sequentially washed with IP buffer, IP buffer
containing 500mM NaCl and LiCl buffer. ChIPmentation was carried out essentially
as previously described using Tagment DNA Enzyme provided by the Proteomic
Service of CABD (Centro Andaluz de Biología del Desarrollo). DNA was eluted by
incubation at 50 °C in 100 μL elution buffer (1% SDS, 100mM NaHCO3), cross-
linking reverted by incubation with 200 mM NaCl and 10 μg of Proteinase K
(ThermoFisher) o/n at 65 °C and DNA purified using Qiagen PCR Purification
columns. Libraries were amplified for N-1 cycles (being N the optimum Cq
determined by qPCR reaction) using NEBNext High-Fidelity Polymerase (M0541,
New England Biolabs), purified using Sera-Mag Select Beads (GE Healthcare) and
sequenced using Illumina NextSeq 500 and single-end configuration.
NGS analysis. Tags were aligned to mouse genome (mm9) using Bowtie (version
1.2.0). Peaks were called using HOMER and filtered by a fold change enrichment
over control (IgG ChIPseq) of 10-fold and standard quality parameters for “factor-
style” peak calling. When comparing peak colocalization, TOP2B called peaks were
extended 1 kb in each direction. For genome tracks, we used bamCoverage
(deepTools) to convert aligned reads to signal tracks (bigwig) using RPKM nor-
malization. Visualization was done by UCSC browser and profiles and heatmaps
were generated by Seqplots applying k-means algorithm for clustering. Two
experiments with two different antibodies against TOP2B were performed in the
study and one for TOP2A isoform. In order to increase the confidence of TOP2B
peaks, TOP2B peak dataset was based on both experiments and defined as the
common peaks called in the two replicates. For genome browser tracks, TOP2B
ChIPseq performed using NOVUS Biologicals antibody (NB100-40842) was used.
Genome annotation was obtained from UCSC classification. V, D, J segment
annotations were obtained from Ji et al.39. All comparisons are performed with
datasets derived from thymocytes except RAD21 data, which is derived specifically
from CD4/CD8 DP thymocytes. Since DP is the most abundant (>90%) population
of thymocytes, we consider this dataset valid for comparison with experiments
performed in total thymocytes. RAG1 and RAG2 ChIPseq in thymocytes were
obtained from Teng et al. 2015 (SRA: PRJNA285688)40, thymocyte ENDSeq
datasets from Canela et al. 2016 (SRA: PRJNA326246)38, TOP2B ChIPseq in MEFs
from Canela et al. (SRA: PRJNA387544)37 and RAD21 ChIPseq in CD4+CD8+ DP
thymocytes from Loguercio et al. (SRA: PRJNA432324)47. POLR2A, H3K4me3,
H3K27ac and CTCF thymocyte datasets were obtained from ENCODE
(ENCSR000CEA, ENCSR000CCJ, ENCSR000CCH and ENCSR000CDZ
respectively). All the raw reads from the mentioned available ChIPseq and ENDseq
experiments were processed following the pipeline described above.
Hi–C analysis. Hi–C data was obtained from Falk et al.41 (GEO accession number:
GSE111032) and available contact matrixes displayed using HiGlass web-tool
(http://higlass.io).
Software and algorithms. UCSC Genome Browser – Kent et al. 2002. https://
genome.ucsc.edu
HiGlass - Kerpedjiev et al. 2018. https://higlass.io/
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Bowtie 1.2.0. – Langmead et al. 2009. https://sourceforge.net/projects/bowtie-
bio/files/bowtie
MACS – Zhang et al. 2008. https://pypi.python.org/pypi/MACS
HOMER – Heinz et al. 2010. https://homer.ucsd.edu/homer
SAMTOOLS-1.1 – Li et al. 2009. https://github.com/samtools/samtools
deepTools-2.4.1. – Ramirez et al. 2016. https://deeptools.readthedocs.io
R – R Development Core Team, 2008. https://www.r-projects.org
SeqPlots – Stempor et al. 2016. https://github.com/Przemol/seqplots
GraphPad Prism v6. for statistical analysis. https://graphpad.com
FastQ Toolkit - http://hannonlab.cshl.edu/fastx_toolkit/
Trimmomatic - Bolger et al. 2014. https://doi.org/10.1093/bioinformatics/
btu170
BD CellQuest pro and FlowJo v9. for FACS analysis.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Next-generation sequencing data are available at the Gene Expression Omnibus (GEO)
database under accession number GSE133954 and CGH arrays have been deposited at
the GEO database under accession number GSE134054 All the other data supporting the
findings of this study are available within the article. Additionally, a source data file for
Figs. 1–7 and Supplementary Figs. 1 and 2 is provided.
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